Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DRIZALMA SPRINKLE safely and effectively. See full prescribing information for DRIZALMA SPRINKLE. DRIZALMA SPRINKLE™ (duloxetine delayed-release capsules), for oral use. Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
DRIZALMA SPRINKLE is indicated for the treatment of: •Major Depressive Disorder in adults •Generalized Anxiety Disorder in adults and pediatric patients 7 years of age and older •Diabetic Peripheral Neuropathy in adults • Fibromyalgia in adults •Chronic Musculoskeletal Pain in adults Additional pediatric use information is approved for Eli Lilly and Company, Inc.’s CYMBALTA (duloxetine delayed-release capsules). However, due to Eli Lilly and Company Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
- generic_name
- duloxetine
- product_names
- Duloxetine
- ndc
- 47335-616, 47335-617, 47335-618, 47335-619, 47335-616-30, 47335-616-90, 47335-616-10, 47335-616-60, 47335-617-90, 47335-617-10, 47335-617-30, 47335-617-60, 47335-618-90, 47335-618-10, 47335-618-30, 47335-618-60, 47335-619-30, 47335-619-90, 47335-619-10, 47335-619-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en